Ceftriaxone ( ) Active Pharmaceutical Ingredient recalls
The FDA has published 1 recall involving Ceftriaxone ( ) Active Pharmaceutical Ingredient since 2016. The latest was reported on 8 Jun 2016. Most were for manufacturing (cgmp) deviations. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2016
Last 12 months0reported
Class I00% of total
Ongoing0latest 8 Jun 2016
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 0 0%Class III 1 100%
Why ceftriaxone ( ) active pharmaceutical ingredient is recalled
Companies
By year
All ceftriaxone ( ) active pharmaceutical ingredient recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Ceftriaxone Sodium (Sterile) USP active pharmaceutical recalled | Lupin Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
Should you stop taking Ceftriaxone ( ) Active Pharmaceutical Ingredient?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.